SCHEMBL20111265

SCHEMBL20111265

CCOc1ccc2c(c1F)-c1c-2cc(-c2ccc(C3CCCCC3)c(F)c2)c(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CAMKK1 Q8N5S9 2/20 0.36
CAMKK2 Q96RR4 2/20 0.36
PTGDR2 Q9Y5Y4 3/20 0.36
PTGDR Q13258 1/20 0.36
FGFR2 P21802 2/20 0.35
FFAR4 Q5NUL3 1/20 0.35
PTPRC P08575 1/20 0.34
FEN1 P39748 5/20 0.34
ALOX5AP P20292 4/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
FGFR1 P11362 1/20 0.33
FPR2 P25090 1/20 0.32
NAAA Q02083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21609925 0.90 FEN1 (0.40) CAMKK1CAMKK2PTGDR2PTGDRFGFR2
SCHEMBL20102541 0.85 FFAR4 (0.34) FGFR2FFAR4FGFR1
SCHEMBL20111583 0.84 PTGDR2 (0.39) CAMKK1CAMKK2PTGDR2PTGDRFEN1
SCHEMBL20102455 0.84 PTGDR2 (0.39) CAMKK1CAMKK2PTGDR2PTGDRFEN1
SCHEMBL20102450 0.83 PTGDR2 (0.37) CAMKK1CAMKK2PTGDR2PTGDRFGFR2
SCHEMBL15381647 0.82 FPR2 (0.41) CAMKK1CAMKK2FGFR2FFAR4PTPRC
SCHEMBL20111290 0.81 PTGDR2 (0.37) CAMKK1CAMKK2PTGDR2PTGDRFEN1
SCHEMBL20102451 0.81 ALOX5AP (0.36) CAMKK1CAMKK2PTGDR2FGFR2FEN1
SCHEMBL20111356 0.79 FEN1 (0.38) CAMKK1CAMKK2PTGDR2FEN1ALOX5AP
SCHEMBL20111581 0.79 PTGDR2 (0.37) CAMKK1CAMKK2PTGDR2PTGDRFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S CAMKK1 2225/4885CAMKK2 2756/4885PTGDR2 1255/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S CAMKK1 2225/4885CAMKK2 2756/4885PTGDR2 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.